KindlyMD (NAKA) Stock Price, News & Analysis

Company Overview

Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.

Key Stats

• Today's Range: $13.01 to $15.60
• 50-Day Range: $6.35 to $18.34
• 52-Week Range: $0.65 to $34.77
• Volume: 595,658 shs
• Average Volume: 587,373 shs
• Market Capitalization: $104.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NAKA Stock Analysis - Frequently Asked Questions

How have NAKA shares performed this year?

KindlyMD's stock was trading at $11.60 at the beginning of the year. Since then, NAKA stock has increased by 17.8% and is now trading at $13.67.

How were KindlyMD's earnings last quarter?

KindlyMD, Inc. (NASDAQ:NAKA) issued its earnings results on Tuesday, August, 5th. The company reported ($0.34) earnings per share (EPS) for the quarter. The firm had revenue of $0.41 million for the quarter. KindlyMD had a negative net margin of 244.00% and a negative trailing twelve-month return on equity of 131.09%.

How do I buy shares of KindlyMD?

Shares of NAKA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/05/2025
• Today: 8/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:NAKA
• CIK: 1946573
• Web: N/A
• Phone: (385) 388-8220
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.86)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.62 million
• Net Margins: -244.00%
• Pretax Margin: -244.00%
• Return on Equity: -131.09%
• Return on Assets: -106.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 13.00
• Quick Ratio: 13.00

Sales & Book Value

• Annual Sales: $2.72 million
• Price / Sales: 38.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.18 per share
• Price / Book: 11.58

Miscellaneous

• Outstanding Shares: 7,610,000
• Free Float: 4,504,000
• Market Cap: $104.03 million
• Optionable: N/A
• Beta: 34.35